Adults seeking an ADHD assessment in the UK have three routes available: the standard NHS pathway, a private self-funded assessment, and the NHS Right to Choose pathway which sits between the two. The clinical process and diagnostic standards are the same across all three when the assessment is conducted by a qualified specialist. What differs is the waiting time, the cost, how prescribing gets managed afterwards, and how much control the adult has over who assesses them and when.
According to Psychiatrist in UK at Insight Diagnostics, “the route matters less than the quality of the clinician doing the assessment a well-conducted private assessment and a well-conducted NHS assessment are clinically equivalent, but with NHS waits now running to years in many areas, the route does significantly affect when someone can actually access that quality of care.”
Trying to work out which route makes sense for you? Book an Assessment
Private vs NHS ADHD Assessment: Key Differences
| NHS | Private | Right to Choose | |
|
Cost |
Free | Self-funded | NHS-funded |
|
Wait time |
Months to years | Days to weeks |
Faster than local NHS |
| GP referral needed | Yes | No |
Yes |
| Clinician choice | Limited | Yes |
Yes |
How Do the Two Pathways Compare on Quality, Access, and What They Actually Involve?
Clinically, a proper assessment is a proper assessment regardless of who’s funding it. Both routes use the same diagnostic criteria, the same structured interview tools, the same NICE guidelines. Where they diverge is everything surrounding the clinical encounter the wait, the scheduling, and what happens when you need to make changes to treatment later.
Waiting time: A 2024 paper in BJPsych Bulletin documented NHS adult ADHD services as being in crisis, with waiting lists reaching unprecedented lengths across much of the UK; private providers typically offer appointments within one to two weeks of booking.
Cost: NHS assessment and subsequent prescribing are free at the point of use; private assessments in the UK run roughly £500 to £900 depending on the provider, with titration and follow-up adding further cost during the post-diagnosis period.
Clinician choice: With a private assessment you can select the specific consultant you want to see, review their background, and pick appointment times that suit you; the NHS pathway allocates whoever is next available within a local service.
Post-diagnosis prescribing: NHS titration sits naturally within the existing system; with a private diagnosis, a shared care agreement is needed for your GP to take over NHS prescribing, and some GPs decline which is worth finding out before you pay for the assessment.
Details on what the assessment process actually involved at Insight Diagnostics are on the ADHD assessment page.
What Is Right to Choose, and Is It Worth Asking Your GP About?
Right to Choose is the option most people either haven’t heard of or haven’t asked their GP about. It’s NHS-funded, faster than the standard NHS pathway in most cases, and available to adults in England. It doesn’t suit everyone, and it’s not available everywhere, but for a lot of adults it closes the gap between “free but years away” and “available next week but expensive.”
How it works: Your GP refers you to an NHS-approved independent provider rather than the local NHS waiting list; the assessment is fully funded and the report carries the same clinical weight as any NHS or private diagnosis.
Speed: Regional NHS waits ranged from four weeks to 3.8 years in Freedom of Information data reviewed in a 2022 PMC study on mainstreaming ADHD in UK primary care; Right to Choose providers typically see patients within weeks rather than years.
GP cooperation: Your GP needs to agree to the referral, and some are more familiar with Right to Choose than others going in with the name of a specific approved provider makes the conversation considerably easier than asking in the abstract.
Prescribing after Right to Choose: Because the assessment is NHS-funded, the transition to ongoing prescribing through your GP is generally more straightforward than it can be with a fully private diagnosis, though it still depends on local shared care policies.
If you want to understand what NHS waiting times currently look like and how the Right to Choose pathway compares in practice, the guide on the NHS waiting list covers the detail clearly.
Why Choose Insight Diagnostics for knowing the difference between Private and NHS ADHD Assessment?
Insight Diagnostics is a CQC-regulated service led by GMC-registered consultant psychiatrists with extensive NHS experience in adult ADHD and neurodevelopmental conditions. It’s an approved NHS Right to Choose provider, accepts Vitality and Aviva insurance, and issues diagnostic reports within five working days. Call 020 3657 0737 to book your consultation.
Adults seen here get the same consultant-led psychiatric interview whether they’re coming through Right to Choose, private funding, or insurance — the route changes, the clinical standard doesn’t.
📞Call Now: 020 3657 0737 to book your consultation.
FAQ’s
Is a private ADHD diagnosis accepted by NHS GPs?
Most NHS GPs accept a private ADHD diagnosis from a GMC-registered consultant psychiatrist, though GP acceptance of shared care prescribing varies and is worth confirming before you book.
What is the NHS Right to Choose pathway for ADHD?
Right to Choose allows adults in England to ask their GP for a referral to an NHS-funded independent provider rather than waiting for their local NHS service, typically resulting in faster access.
How long is the NHS waiting list for adult ADHD assessment?
NHS waiting times vary significantly by region, ranging from a few months in better-resourced areas to several years where backlogs are severe.
Are private and NHS ADHD assessments equally thorough?
A private assessment conducted by a GMC-registered consultant psychiatrist following NICE guidelines is clinically equivalent to an NHS assessment; the key variable is the quality of the provider, not the funding route.
References
- Smith MC et al. UK adult ADHD services in crisis. BJPsych Bulletin. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC10801359/
- Sayal K et al. Mainstreaming adult ADHD into primary care in the UK: guidance, practice, and best practice recommendations. PMC. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9553294/